Leukotrienes in cardiovascular diseases.
Folco
G
G
Center for Cardiopulmonary Pharmacology, Institute of Pharmacological Sciences, University of Milan, Milan, Italy. giancarlo.folco@unimi.it
Rossoni
G
G
Buccellati
C
C
Berti
F
F
Maclouf
J
J
Sala
A
A
D000818:Animals; D002318:Cardiovascular Diseases / Q000378:metabolism* / Q000503:physiopathology; D004562:Electrocardiography / Q000187:drug effects; D006321:Heart / Q000187:drug effects; D066298:In Vitro Techniques; D015289:Leukotrienes / Q000378:metabolism*; D016859:Lipoxygenase Inhibitors / Q000494:pharmacology; D008297:Male; D009206:Myocardium / Q000378:metabolism; D009195:Peroxidase / Q000187:drug effects / Q000378:metabolism; D011804:Quinolines / Q000494:pharmacology; D011817:Rabbits; D011897:Random Allocation
D015289:Leukotrienes; D016859:Lipoxygenase Inhibitors; D011804:Quinolines; C079315:2-(4-(quinolin-2-yl-methoxy)phenyl)-2-cyclopentylacetic acid; D009195:Peroxidase